Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety

被引:59
作者
Cohen, Frederick [1 ]
Aggen, James B. [1 ]
Andrews, Logan D. [1 ]
Assar, Zahra [2 ]
Boggs, Jen [1 ]
Choi, Taylor [1 ]
Dozzo, Paola [1 ]
Easterday, Ashton N. [1 ]
Haglund, Cat M. [1 ]
Hildebrandt, Darin J. [1 ]
Holt, Melissa C. [2 ]
Joly, Kristin [3 ]
Jubb, Adrian [1 ]
Kamal, Zeeshan [4 ]
Kane, Timothy R. [1 ]
Konradi, Andrei W. [5 ]
Krause, Kevin M. [1 ]
Linsell, Martin S. [1 ]
Machajewski, Timothy D. [1 ]
Miroshnikova, Olga [4 ]
Moser, Heinz E. [1 ]
Nieto, Vincent [1 ]
Thu Phan [4 ]
Plato, Craig [3 ]
Serio, Alisa W. [1 ]
Seroogy, Julie [1 ]
Shakhmin, Anton [4 ]
Stein, Adam J. [2 ]
Sun, Alex D. [4 ]
Sviridov, Serguei [4 ]
Wang, Zhan [4 ]
Wlasichuk, Kenneth [1 ]
Yang, Wen [4 ]
Zhou, Xiaoming [6 ]
Zhu, Hai [4 ]
Cirz, Ryan T. [1 ]
机构
[1] Achaogen Inc, 1 Tower Pl,Suite 400, San Francisco, CA 94080 USA
[2] Cayman Chem Co, 1180 East Ellsworth, Ann Arbor, MI 48108 USA
[3] Plato BioPharma Inc, Unit 300, 7581 West 103rd Ave, Westminster, CO 80021 USA
[4] Nanosyn Inc, 3100 Cent Expressway, Santa Clara, CA 95051 USA
[5] Konradi Mol, 30 Victoria Rd, Burlingame, CA 94010 USA
[6] Pharmaron Inc, BDA, 6 Tai He Rd, Beijing 100176, Peoples R China
基金
美国国家卫生研究院;
关键词
amines; antibiotics; inhibitors; LpxC; prodrugs; Pseudomonas; zwitterions; DRUGS;
D O I
10.1002/cmdc.201900287
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) is a Zn2+ deacetylase that is essential for the survival of most pathogenic Gram-negative bacteria. ACHN-975 (N-((S)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1R,2R)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diyn-1-yl)benzamide) was the first LpxC inhibitor to reach human clinical testing and was discovered to have a dose-limiting cardiovascular toxicity of transient hypotension without compensatory tachycardia. Herein we report the effort beyond ACHN-975 to discover LpxC inhibitors optimized for enzyme potency, antibacterial activity, pharmacokinetics, and cardiovascular safety. Based on its overall profile, compound 26 (LPXC-516, (S)-N-(2-(hydroxyamino)-1-(3-methoxy-1,1-dioxidothietan-3-yl)-2-oxoethyl)-4-(6-hydroxyhexa-1,3-diyn-1-yl)benzamide) was chosen for further development. A phosphate prodrug of 26 was developed that provided a solubility of >30 mg mL(-1) for parenteral administration and conversion into the active drug with a t(1/2) of approximately two minutes. Unexpectedly, and despite our optimization efforts, the prodrug of 26 still possesses a therapeutic window insufficient to support further clinical development.
引用
收藏
页码:1560 / 1572
页数:13
相关论文
共 26 条
  • [1] [Anonymous], 2007, PRODRUGS BIOTECHNOLO, DOI DOI 10.1007/978-0-387-49785-3_16
  • [2] [Anonymous], 2015, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: M07-A10
  • [3] Approved Standard
  • [4] [Anonymous], 2013, Antibiotic resistance threats in the United States, 2013
  • [5] Re-estimating annual deaths due to multidrug-resistant organism infections
    Burnham, Jason P.
    Olsen, Margaret A.
    Kollef, Marin H.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2019, 40 (01) : 112 - 113
  • [6] Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae - Washoe County, Nevada, 2016
    Chen, Lei
    Todd, Randall
    Kiehlbauch, Julia
    Walters, Maroya
    Kallen, Alexander
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2017, 66 (01): : 33 - 33
  • [7] Cohen F., 2017, Int. PCT Pub., Patent No. [WO2017223349, 2017223349]
  • [8] THE IMPORTANCE OF THE GEOMETRIC MEAN MIC
    DAVIES, BI
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (03) : 471 - 472
  • [9] Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC
    Erwin, Alice L.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2016, 6 (07):
  • [10] Exploring the UDP pocket of LpxC through amino acid analogs
    Hale, Michael R.
    Hill, Pamela
    Lahiri, Sushmita
    Miller, Matthew D.
    Ross, Philip
    Alm, Richard
    Gao, Ning
    Kutschke, Amy
    Johnstone, Michele
    Prince, Bryan
    Thresher, Jason
    Yang, Wei
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (08) : 2362 - 2367